It is not a placeholder. AAIC accepts new data only. It does not on blind faith accept the mere hope or intention to present new data. The 12-wk PK/PD analysis will assess dose dependency, so there is no reason in that choice of words to consider Anavex's poster title a rehash.
Market Data 
Markets 
AI
